middle.news
Chimeric Therapeutics Raises $8.4M to Fully Fund Lead CAR-T Trial
10:02am on Tuesday 23rd of December, 2025 AEDT
•
Healthcare
Read Story
Chimeric Therapeutics Raises $8.4M to Fully Fund Lead CAR-T Trial
10:02am on Tuesday 23rd of December, 2025 AEDT
Key Points
$8.4 million raised via $4.4M placement and $4M convertible note
Funding fully covers CHM CDH17 CAR-T trial through Phase 1, including increased dose cohort
Strategic reset underway – cost reductions, share consolidation proposal, and Board renewal
Chief Medical Officer resigns; clinical oversight to be streamlined
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Chimeric Therapeutics (ASX:CHM)
OPEN ARTICLE